Viewing Study NCT01558869


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-25 @ 8:24 PM
Study NCT ID: NCT01558869
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2012-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma
Sponsor: The University of Hong Kong
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module